← Eichor
Study identifier: NCT04302116 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm

Condition: Infantile Spasm · West Syndrome  ·  Sponsor: Kullasate Sakpichaisakul

PhaseNA
Planned participants250
Who can joinAll sexes, 2 Months to 14 Months
Healthy volunteersNo

About this study

Infantile spasms (IS) are seizures associated with a severe infantile epileptic encephalopathy. Both cessation of spasms and electrographic response are necessary for the best neurodevelopmental outcomes. Adrenocorticotrophic hormone (ACTH), or prednisolone, or vigabatrin are considered the first-line treatment individually. However, ACTH expense and availability are the barriers in developing countries including Thailand. Vigabatrin, therefore, is the first recommended by Epilepsy Society of Thailand due to ACTH unavailability. Recently, combined steroid treatments (either ACTH or high dose prednisolone) with vigabatrin are superior in cessation of spasms compared to steroid treatment alone. Thus, this study is aimed to compare the efficacy of vigabatrin with high dose prednisolone combination therapy and vigabatrin alone.

This description comes directly from the study's public registry record.

Talk to the study team

Kullasate Sakpichaisakul, MD  ·  66-2-354-8333  ·  kullasate.s@rsu.ac.th

Sirorat Suwannachote, MD  ·  66-2-354-8333  ·  sirorat.s@rsu.ac.th

Always discuss trial participation with your own doctor first.

Locations (1)

Queen Sirikit National Institute of Child HealthRatchathewi, Bangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04302116